Prescription For Failure: Why Trump’s Drug Plan Is Bad w/ Yale Economist Jason Abaluck

Two weeks after Donald Trump announced he was going to lower drug prices from anywhere from 30% to 90%, there still haven't been any deals made. But more than that, what he wants to do, something called Most Favored Nation status, is bad policy, especially when it comes to drug prices. Grant is joined by Yale Economist Jason Abaluck to talk about why Trump's plan to lower drug prices won't lower them, might raise prices, could stifle medical innovation at home and abroad, and what that means for your next prescription. LINKS:Jason Abaluck's ResearchSupport the showFollow along on social media SaySo: @GrantHermes X: @GrantHermesInsta: @Grant__HermesTiktok: Grant_Hermes